Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
JAMAPublished 13 September 2000
Fred E. Silverstein, Gerald A. Faich, Jay L. Goldstein, Lee S. Simon, Theodore Pincus, Andrew Whelton
Citations3,151
SJR quartileQ1
SJR score5.35
SNIP10.71
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
In this study, celecoxib, at dosages greater than those indicated clinically, was associated with a lower incidence of symptomatic ulcers and ulcer complications combined, as well as other clinically important toxic effects, compared with NSAIDs at standard dosages.
Abstract
In this study, celecoxib, at dosages greater than those indicated clinically, was associated with a lower incidence of symptomatic ulcers and ulcer complications combined, as well as other clinically important toxic effects, compared with NSAIDs at standard dosages. The decrease in upper GI toxicity was strongest among patients not taking aspirin concomitantly. JAMA. 2000;284:1247-1255
Keywords
Medicine
Arthritis & RheumatismEstimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States
2,660 Citations1998Reva C. Lawrence, Charles G. Helmick +12 more
Given the limitations of the data on which they are based, this report provides the best available prevalence estimates for arthritis and other rheumatic conditions overall, and for selected musculoskeletal disorders, in the US population.
Proceedings of the National Academy of SciencesSystemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2
1,308 Citations1999Brendan McAdam, Francesca Catella-Lawson +4 more
Annals of Internal MedicineRisk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs
1,242 Citations1991Sherine E. Gabriel, Liisa Jaakkimainen +1 more
Users of NSAIDs are at approximately three times greater relative risk for developing serious adverse gastrointestinal events than are nonusers.
Annals of Internal MedicineMisoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory Drugs
1,060 Citations1995Fred E. Silverstein, David Y. Graham +5 more
This objective was to determine whether concurrent therapy with misoprostol reduces the incidence of serious upper gastrointestinal complications in older patients with chronic rheumatoid arthritis who are taking NSAIDs.
The LancetRisks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs
874 Citations1994M. J. S. Langman, J Weil +7 more
Assessment of previous use of NSAIDs in patients aged 60 and older admitted to hospitals in five large cities with peptic ulcer bleeding found the lowest possible doses should be used; and the least toxic NSAIDs should be selected.
BMJVariability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis
827 Citations1996David Henry, L. Lim +10 more
The low risk of serious gastrointestinal complications with ibuprofen seems to be attributable mainly to the low doses of the drug used in clinical practice, and in higher doses ib uprofen is associated with a similar risk to other non-steroidal anti-inflammatory drugs.
JAMAAnti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid Arthritis
804 Citations1999Lee S. Simon, Arthur L. Weaver +9 more
All dosages of celecoxib were efficacious in the treatment of rheumatoid arthritis and did not affect COX-1 activity in the GI tract mucosa as evidenced by less frequent incidence of endoscopic ulcers compared with naproxen.
Annals of Internal MedicineNonsteroidal Anti-inflammatory Drug Use and Increased Risk for Peptic Ulcer Disease in Elderly Persons
764 Citations1991Marie R. Griffin, Joyce M. Piper +3 more
The data support other findings indicating that a clinically significant risk for serious ulcer disease is associated with the use of nonaspirin nonsteroidal anti-inflammatory drugs and that use of these drugs may be responsible for a large proportion of peptic ulcers among elderly persons.
The American Journal of MedicineNephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications
681 Citations1999Andrew Whelton
Physiologic factors, clinical presentations, diagnostic modalities, and clinical management strategies appropriate to these NSAID-induced renal syndromes are described.
Journal of Clinical GastroenterologyA Critical Analysis
641 Citations1995Stalnikowicz-Darvasi Ruth
The combination of the results showed that the occurrence of bleeding was 1.5 times higher in patients treated with low-dose aspirin in doses of 75-325 mg/day as compared with placebo.
BMJProphylactic aspirin and risk of peptic ulcer bleeding
568 Citations1995J Weil, D G Colin‐Jones +7 more
No conventionally used prophylactic aspirin regimen seems free of the risk of peptic ulcer complications, and this finding applies to doses in common use of 75, 150, and 300 mg daily.
The LancetCelecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison
539 Citations1999Paul Emery, H. Zeidler +8 more
Celecoxib showed sustained anti-inflammatory and analgesic activity similar to diclofenac, with a lower frequency of upper gastrointestinal ulceration or gastrointestinal adverse events, and tolerability was better.
The LancetRisk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product
418 Citations1996Judith P. Kelly, David W. Kaufman +4 more
Use of low doses of enteric-coated or buffered aspirin carries a three-fold increase in the risk of major UGIB, suggesting the assumption that these formulations are less harmful than plain aspirin may be mistaken.
Biochemical JournalExpression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase
417 Citations1995James K. Gierse, Scott D. Hauser +5 more
The results demonstrate the ability to generate selective non-steroidal anti-inflammatory drugs (NSAIDs), which could provide useful improvement therapeutically in the treatment of chronic inflammatory disease.
New England Journal of MedicineNonsteroidal Antiinflammatory Drugs
392 Citations1980Jan Koch‐Weser, Lee S. Simon +1 more
Mayo Clinic ProceedingsTreatment of Osteoarthritis With Celecoxib, a Cyclooxygenase-2 Inhibitor: A Randomized Controlled Trial
350 Citations1999W. Bensen, Justus J. Fiechtner +8 more
COX-2 inhibition with celecoxib is an effective approach for the treatment of osteoarthritis, as seen by clinical improvement in signs and symptoms comparable to treatment with naproxen.
Archives of Internal MedicineRisk of Hospitalization for Upper Gastrointestinal Tract Bleeding Associated With Ketorolac, Other Nonsteroidal Anti-inflammatory Drugs, Calcium Antagonists, and Other Antihypertensive Drugs
336 Citations1998L.A. García Rodríguez, Chiara Cattaruzzi +2 more
The excess risk of major upper gastrointestinal tract complications associated with outpatient use of ketorolac suggests an unfavorable risk-benefit assessment compared with other NSAIDs.
American Journal of EpidemiologyNonsteroidal Anti-inflammatory Drugs and the Incidence of Hospitalizations for Peptic Ulcer Disease in Elderly Persons
300 Citations1995Walter Smalley, Wayne A. Ray +2 more
The excess rate of ulcer hospitalization for elderly NSAID users is high, and these drugs should be used with caution in elderly persons, and alternatives to NSAID therapy should be strongly considered.
The American Journal of GastroenterologyReduced Risk of Upper Gastrointestinal Ulcer Complications With Celecoxib, A Novel Cox-2 Inhibitor
300 Citations2000Jay L. Goldstein, Fred E. Silverstein +6 more
The incidence of UGI ulcer complications associated with celecoxib was 8-fold lower than with nonspecific, nonsteroidal anti-inflammatory drugs (NSAIDs), and that in non-NSAID users reported in the literature was similar to that in patients receiving placebo in the RCTs.
BMJAssociation of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study
297 Citations1997Thomas M. MacDonald, S. V. Morant +5 more
Evidence is provided that non-steroidal anti-inflammatory toxicity persists with continuous exposure and there seems to be carryover toxicity after the end of prescribing.
British Journal of Clinical PharmacologyThe gastrointestinal toxicity of aspirin: an overview of randomised controlled trials.
296 Citations1993PJ Roderick, H Wilkes +1 more
An overview of the gastrointestinal toxicity of aspirin, its most serious complication after intracerebral haemorrhage, is presented and the efficacy of low doses of aspirin (75 mg daily) are demonstrated.
Arthritis & RheumatismBasic biology and clinical application of specific cyclooxygenase-2 inhibitors
294 Citations2000Leslie J. Crofford, Peter E. Lipsky +4 more
Clinical trials demonstrate the potential for clinically meaningful reductions in the incidence of the most serious GI complications found with nonselective NSAIDs, i.e., ulcer, perforation, and GI bleeding.
Biochemical JournalKinetic basis for selective inhibition of cyclo-oxygenases
279 Citations1999James K. Gierse, Carol M. Koboldt +3 more
Although IC50 determinations are useful for structure/activity analyses, the complex and distinct mechanisms of enzyme inhibition of each COX isoform by the NSAIDs renders comparison of inhibitory activity on COX-1 andCOX-2 using IC50 ratios of questionable validity.
PubMedNSAID induced gastrointestinal complications: the ARAMIS perspective--1997. Arthritis, Rheumatism, and Aging Medical Information System.
245 Citations1998Gaurav Singh, Dena Rosen Ramey
Whether GI side effects such as dyspepsia can serve as warning symptoms for serious GI complications and describes the risk factors for these life threatening complications are described.
Arthritis & RheumatismPreference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: A survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia
234 Citations2000Frederick Wolfe, Sean Z. Zhao +1 more
There was a considerable and statistically significant preference for NSAIDs compared with acetaminophen among the 3 groups of rheumatic disease patients, and this preference decreased slightly with age and was less pronounced in OA patients.
EpidemiologyIndividual Nonsteroidal Antiinflammatory Drugs and Other Risk Factors for Upper Gastrointestinal Bleeding and Perforation
223 Citations1997Susana Perez‐Gutthann, Luis A. García‐Rodríguez +1 more
Simultaneous use of multiple NSAIDs as well as use of a single individual NSAID at high doses greatly increases the risk of complicated peptic ulcer disease.
American Journal of TherapeuticsGastrointestinal Complications of Prescription and Over-the-Counter Nonsteroidal Anti-inflammatory Drugs
201 Citations2000Gurkirpal Singh
Although the relative risk of OTC doses of NSAIDs is less than the previously published risk of prescription doses, it remains clinically significant and a matter of serious concern because of the widespread use of these medications and an underappreciation of the true risk.
PubMedPreference for nonsteroidal antiinflammatory drugs versus acetaminophen and concomitant use of both types of drugs in patients with osteoarthritis.
124 Citations2000Theodore Pincus, Christopher J. Swearingen +2 more
Patients take many different drugs for OA, most of which are not continued beyond 2 years, and most patients who identified a drug as "most helpful" named an NSAID rather than acetaminophen or an analgesic drug.
Scandinavian Journal of GastroenterologyNonsteroidal Anti-inflammatory Drugs and Upper Gastrointestinal Bleeding, Identifying High-Risk Groups by Excess Risk Estimates
111 Citations1995Jesper Hallas, Jens Lauritsen +2 more
A history of peptic ulcer is associated with adverse outcome of NSAID therapy and should be regarded as a relative contraindication, and the incidence ofNSAID-related UGB can probably be reduced without affecting the overall utilization of NSAIDs.
Archives of Internal MedicinePeptic Ulcer and Gastrointestinal Hemorrhage Associated With Nonsteroidal Anti-inflammatory Drug Use in Patients Younger Than 65 Years
62 Citations1995Lee L. Lanza
Combining use of automated claims records with review of medical records promotes efficiency while maintaining specificity of case ascertainment, and finds a consistent pattern of decreasing NSAID effects from current to recent to past exposure.
American Journal of TherapeuticsCOX-2???Specific Inhibitors: Definition of a New Therapeutic Concept
58 Citations2001Kenneth M. Verburg, Timothy J. Maziasz +4 more
The criteria that must be met to characterize a compound as COX-2-specific are outlined and clinical evidence of clear improvement in gastrointestinal tolerability and safety must be demonstrated in addition to complementary evidence of COx-2 selectivity obtained from enzyme, biochemical, and clinical pharmacology evaluations.